India's government is proposing stricter regulations for cough syrups following international alerts about child deaths linked to Indian-made products. Amendments to existing laws aim to tighten criteria for over-the-counter sales. Concurrently, the government has banned oral formulations of Nimesulide above 100 grams, citing safer alternatives. The proposed changes also seek to remove the exemption for "syrups" from certain sales license requirements in small villages, impacting household remedies.